Financial News

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Moderna, Inc. - Common Stock (NQ:MRNA)

24.91 -2.25 (-8.28%)
Streaming Delayed Price Updated: 4:00 PM EST, Nov 3, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Moderna, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Moderna Stock Slides After-Hours On CMV Vaccine Failure In Phase 3 Trial — Retail Traders Warn Of ‘Endless’ Cash Burn
The biotech will continue testing the vaccine in bone marrow transplant patients, where CMV reactivation can cause serious complications, and said no safety concerns were identified. 
Via Stocktwits
What's going on in today's after hours session: S&P500 movers
Discover the top S&P500 movers in Wednesday's after-hours session and stay informed about the post-market dynamics. 
Via Chartmill
Global Economic Freedom in Retreat: A Four-Year Decline Signals Looming Market Shifts
Washington D.C., October 22, 2025 – The world stands at a critical juncture as the 2025 Economic Freedom of the World index, prominently released by the Fraser Institute in collaboration with the Cato... 
Via MarketMinute
Topics Bonds Brexit Economy
Moderna Announces Phase 3 Study of Investigational Cytomegalovirus (CMV) Vaccine Did Not Meet Primary Efficacy Endpoint
Via ACCESS Newswire
Prediction: Moderna Will Soar Over the Next 5 Years. Here's 1 Reason Why.
The biotech's innovative qualities will come in handy. 
Via The Motley Fool
Should You Buy Moderna Right Now?
Shares could keep sliding, as Moderna's post-COVID pipeline has yet to reach a breakthrough. 
Via The Motley Fool
Topics Bonds
Wellgistics And DataVault Team Up To Transform Prescription Tracking
DataVault AI and Wellgistics Health are collaborating to bring blockchain technology to the US prescription drug market. 
Via Benzinga
Topics Artificial Intelligence
These 3 Beaten-Down Healthcare Stocks Could Have Farther to Fall
Don't try to catch a falling surgical knife. 
Via The Motley Fool
Topics Government
Dow Jumps More Than 500 Points Ahead Of Earnings: Investor Fear Eases, Greed Index Remains In 'Fear' Zone
U.S. stocks rise on Monday, with the Dow up 500+ points. Moderna and Cleveland-Cliffs report gains. Most S&P sectors close higher, with Fear & Greed Index at 30.3. 
Via Benzinga
Topics Stocks
Small Caps Rally As Credit Fears Ease, Gold Rebounds To $4,350: What's Moving Markets Monday?
Via Benzinga
What's going on in today's session: S&P500 movers
Wondering what's happening in today's session for the S&P500 index? Stay informed with the top movers within the S&P500 index on Monday. 
Via Chartmill
Stay informed with the top movers within the S&P500 index on Monday.
Let's have a look at the top S&P500 gainers and losers in the middle of the day of today's session. 
Via Chartmill
Stock Market Today: S&P 500, Nasdaq, Dow Jones Futures Rise— Micron, Bitmine, Coinbase In Focus
U.S. stock futures rose on Monday following Friday’s advances. Futures of major benchmark indices were higher. 
Via Benzinga
Topics Stocks
2 Mid-Cap Stocks to Consider Right Now and 1 That Underwhelm
Mid-cap stocks have the best odds of scaling into $100 billion corporations thanks to their tested business models and large addressable markets. But the many opportunities in front of them attract... 
Via StockStory
Biotech Boom: Strategic Realignments and AI Integration Fuel Investor Focus, Signaling Broader Market Shifts
The biotechnology sector is currently experiencing a significant surge in investor attention, characterized by a blend of cautious optimism and strategic focus. As of October 2025, this heightened... 
Via MarketMinute
Topics Artificial Intelligence ETFs Economy
Moderna Highlights Seasonal Flu and H5 Pandemic Flu Candidates at IDWeek 2025
Via ACCESS Newswire
Healthcare’s AI Revolution: Generative Intelligence Delivers Real Returns as Agentic Systems Drive Measurable Outcomes
The healthcare industry is experiencing a profound transformation, propelled by the accelerating adoption of artificial intelligence. While AI's potential has long been discussed, recent advancements... 
Via TokenRing AI
Topics Artificial Intelligence Economy
Uncover the latest developments among S&P500 stocks in today's session.
Wondering what's happening in today's session for the S&P500 index? Stay informed with the top movers within the S&P500 index on Friday. 
Via Chartmill
Moderna to Report Third Quarter 2025 Financial Results on Thursday, November 6, 2025
Via ACCESS Newswire
Why Moderna Might Be a One-Hit Wonder
Moderna's sales have plummeted in recent years along with diminishing demand for COVID vaccines. 
Via The Motley Fool
Which S&P500 stocks are moving on Wednesday?
Let's delve into the developments on the US markets one hour before the close of the markets on Wednesday. Below, you'll find the top gainers and losers within the S&P500 index during today's session. 
Via Chartmill
Wednesday's session: top gainers and losers in the S&P500 index
Let's have a look at what is happening on the US markets in the middle of the day on Wednesday. Below you can find the top S&P500 gainers and losers in today's session. 
Via Chartmill
Government Shutdown Casts Long Shadow Over Economy and Interest Rate Outlook Ahead of Powell's Pivotal Speech
The United States government is currently in the throes of its third week of a shutdown, a fiscal impasse that commenced on October 1, 2025, following a congressional failure to enact appropriations... 
Via MarketMinute
Topics Economy Government Regulatory Compliance
Hedge Fund Shah Capital Urges Novavax To Consider Sale Amid Vaccine Rollout Struggles, Sees $5 Billion Potential
Shah Capital urges Novavax to consider a sale after poor COVID-19 vaccine rollout, highlighting the potential value of at least $5 billion. 
Via Benzinga
David Gardner: 9 Foolish Truths I Hold to Be Self-Evident
Whether you're well steeped in Foolishness or at the beginning stages of your investing journey, these are nine foundational truths not to be forgotten. 
Via The Motley Fool
Moderna (MRNA) Stock Trades Up, Here Is Why
Shares of biotechnology company Moderna (NASDAQ:MRNA) jumped in the afternoon session after the company presented promising early data for its investigational cancer antigen therapy, mRNA-4359, from a... 
Via StockStory
Topics Economy Government Stocks
Moderna Reports Promising Response Rates For Skin Cancer Combo Therapy In Resistant Patients
Moderna's Phase 1/2 study shows mRNA-4359 plus pembrolizumab yields 24% response rate and 60% disease control in resistant melanoma patients. 
Via Benzinga
3 Cash-Burning Stocks with Warning Signs
Companies that burn cash at a rapid pace can run into serious trouble if they fail to secure funding. Without a clear path to profitability, these businesses risk dilution, mounting debt, or even... 
Via StockStory
Topics Bankruptcy Cannabis
Moderna Presents Promising Early Data for Its Investigational Cancer Antigen Therapy at the 2025 European Society for Medical Oncology Congress
Via ACCESS Newswire
4 Analysts Assess Moderna: What You Need To Know
 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Use the myMotherLode.com Keyword Search to go straight to a specific page

Popular Pages

  • Local News
  • US News
  • Weather
  • State News
  • Events
  • Traffic
  • Sports
  • Dining Guide
  • Real Estate
  • Classifieds
  • Financial News
  • Fire Info
Terms of Service Privacy Policy
© Copyright 2000-2019 Clarke Broadcasting Corporation. All rights reserved.
Feedback